New Onset Diabetes (NOD) Cohort

Condition: Diabetes, hyperglycemia


Key Inclusion Criteria

  • Between 50-85 years old at the time of enrollment
  • Must be willing to provide blood samples (fasting) at baseline, 6, 12, and 24 months post-enrollment
  • Must have at least 1 parameter of diabetes mellitis in the past 90 days:
    • Fasting blood glucose ≥126 mg/dl
    • Hemoglobin A1c  ≥ 6.5%
    • Random Blood Glucose ≥200 mg/dl
    • 2h post-glucose ≥200mg (11.1 mmol/L) during oral glucose tolerance test

Key Exclusion Criteria

  • Must not have any past history of hyperglycemia and/or diabetes
  • Must not be on active treatment for cancer, carry a current diagnosis of any cancer, and/or investigated for suspicion of recurrence of past cancer (except non-melanoma skin cancer or carcinoma in-situ of the cervix)
  • Must not have any past history of pancreatic cancer

Full Study Name

CPDPC16-01: A Prospective Study to Establish a New Onset Diabetes (NOD) Cohort (IRB no. PRO53823)  


The purpose of this study is to create a large repository of blood samples and data from people with new-onset hyperglycemia and diabetes. A repository is a collection of samples from many different people that facilitates research. The study focuses on adults (50-85 years old) who have recently had one or more blood tests that indicate they may have hyperglycemia and/or diabetes.

The blood samples to be stored are similar to those that patients provide during usual care with their doctors. Researchers cannot yet tell the difference between routine, new-onset hyperglycemia and diabetes and the very few people (less than 1%) who have new-onset diabetes related to cancer. The study aims to find a way to do this by measuring promising markers (indicators) from participants’ blood samples.

Principal Investigator

Yessenia Hernandez-Cruz
Please call between 8 a.m. - 4 p.m. Monday-Friday